Overview

A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total knee arthroplasty.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Treatments:
Edoxaban
Enoxaparin
Enoxaparin sodium
Criteria
Inclusion Criteria:

- Patients undergoing unilateral total knee arthroplasty

Exclusion Criteria:

- Subjects with risks of hemorrhage

- Subjects with thromboembolic risks

- Subjects who weigh less than 40 kg

- Subjects who are pregnant or suspect pregnancy, or subjects who want to become
pregnant.